Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketotifen-eluting contact lens for allergic conjunctivitis
NCT00432757Phase 3Completed
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in allergic conjunctivitis (AC) comparing Ketotifen Lens with Placebo Lens (2 arms). Primary endpoint: Ocular itching. Started Jan 2007; status: completed.
02
Drugs
ketotifen
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT00432757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432757.